Skip to content

BIOCERAM

Active
Private limited company (pre-2019)founded 2004active for 22 yearsTerhulpensesteenweg 422, 3090 Overijse, BelgiumKBO/BCE: BE 0869.701.307
Summary

BIOCERAM has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €638,400 and a net result of €132,135. Equity has been growing by about 17% per year since 2019. Its solvency ranks better than 70% of 144 sector peers (NACE 32, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Official details

Source: KBO
Status
Active since 27-10-2004 Normal situation
Activity
Manufacture of medical and dental instruments and supplies NACE 32500
Joint committee
330 Paritair Comité voor de gezondheidsinrichtingen en -diensten · annual accounts 30-09-2022
Establishment unit
2.143.233.014 3090 Overijse, since 27-10-2004
Financial year end
30 September
Peppol
Reachable since 10-10-2025

Board and ownership

Board

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts to 30-09-2025
Gross margin
€828,511
▼ 14.0%
Turnover
≈ €2.0m
estimated
Profit
€132,135
▼ 53.1%
Equity
€638,400
▲ 26.1%
Total assets
€935,528
▲ 30.6%
Staff
9 FTE
=
Net result -53%: other schema
Filed on 31-03-2026, 30 days before the deadline
Score breakdownraises risk1 change of registered office in 24 monthslowers riskLiquidity: current ratio 2.03, cash €448,842Equity €638,400 (68.2% of total assets)Founded in 2004Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 77% of micro companies in other manufacturing (NACE 32)
Financial strength · tick: 2024
Strong
Solvency 93-3
equity 68.2% of total assets
Liquidity 86-2
short-term debt 31.8% · cash 48.0%
Profitability 86-14
return on assets 14.1%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.3% (1,142 companies, NACE 32, micro)
Last 24 months 12-2024: 0.3% 01-2025: 0.4%▲ +0.1 percentage points vs 12-2024 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.5%▲ +0.1 percentage points vs 03-2025highest value 05-2025: < 0.1%▼ -0.5 percentage points vs 04-2025lowest value 06-2025: < 0.1%● unchanged vs 05-2025lowest value 07-2025: < 0.1%● unchanged vs 06-2025lowest value 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: 0.1%▲ +0.1 percentage points vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.2%▲ +0.1 percentage points vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026 11-2026: 0.2%● unchanged vs 10-2026
Credit of up to €60,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.03 (3.13 in 2024), above the usual 1.5. Short-term debt is 31.8% and cash 48% of total assets. 31.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, micro). It does better than 73% of them on solvency, 85% on liquidity, 74% on profitability and 77% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Liquidity: current ratio 2.03, cash €448,842
NBB · annual accounts
lowers risk · Equity €638,400 (68.2% of total assets)
NBB · annual accounts
lowers risk · Founded in 2004
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 31-03-2026, 30 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
30 days early
2024
34 days early
2023
4 days early
2022
17 days early
2021
30 days early
2020
1 day early
2019
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 17 days before the deadline. In the sector (NACE 32), the median for financial year 2024 was 2 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 31 March (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end01-11-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Result fell in 2025different schema filed ▼ 53.1% View
  • Positive: 7th largest company by equity in Overijse, Manufacturing sectorin the Checked rankings No. 7 View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View

Comparable companies

These companies have the same main activity as BIOCERAM: manufacture of medical and dental instruments and supplies (NACE 32500). They are comparable in size and age: total assets between €1.1m and €1.3m, founded between 1992 and 2012.

CompanyTotal assetsGross margin
BIOCERAM Overijse€0.9m€0.8m
GOTTSCHALK Liège€1.3m€1.1m
SURGICAL INSTRUMENTS BELGIUM Gembloux€1.3m€0.7m
DENTAL LABO DENIL & CO. Aarschot€1.2m€0.8m
DENTAL AESTHETICS DE JAEGER Maldegem€1.3m€1.0m
DE VOETZAAK Brugge€1.2m€0.6m
ORTHO CONSULT Kruisem€1.1m€0.9m
Full comparison

Key facts about BIOCERAM

What is the company number of BIOCERAM?
The company number of BIOCERAM is 0869.701.307. The VAT number is the same number with BE in front: BE 0869.701.307.
Where is BIOCERAM based?
The registered office is at Terhulpensesteenweg 422, 3090 Overijse.Company details
What does BIOCERAM do?
According to the KBO register, the main activity is manufacture of medical and dental instruments and supplies (NACE 32500).
What is the legal form of BIOCERAM?
The legal form of BIOCERAM is Private limited company (pre-2019) (BVBA).
When was BIOCERAM founded?
BIOCERAM was founded on 27-10-2004.
Is BIOCERAM still active?
Yes, BIOCERAM is an active enterprise in the KBO register.
How many employees does BIOCERAM have?
BIOCERAM had an average of 9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does BIOCERAM fall under?
In its 30-09-2022 annual accounts, BIOCERAM states joint committee 330 (Paritair Comité voor de gezondheidsinrichtingen en -diensten).
What is the turnover of BIOCERAM?
The turnover in financial year 2025 is ≈ €2.0m. This figure is estimated from the gross margin of €828,511 and 2,285 comparable companies of the same size. It probably lies between €1.2m and €3.3m. It is a rough estimate.
Is BIOCERAM profitable?
In financial year 2025, BIOCERAM made a profit of €132,135.
Where can I find the annual accounts of BIOCERAM?
BIOCERAM filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BIOCERAM due?
BIOCERAM must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.